Benzphetamine Hydrochloride Tablet
Product Images NDC 17224-672

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Benzphetamine Hydrochloride (NDC 17224-672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Calvin Scott & Co., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17224-672-30_2 (17224 672 30 2)

This is a description of Benzphetamine, a drug prescribed to patients only with a direction to take 1 tablet daily. The manufacturer's national drug code (MFG NDC), as well as the CSNDC, is given, with a caution on the transfer of the drug to anyone other than the patient. The pill, a peach-colored tablet, contains 50 mg of Benzedrine. An expiration date is given, and refill is prohibited. The provider's address and phone number, as well as the Rx and DEA numbers, are given. The information on where this drug is being distributed from is also provided. The alphanumeric characters at the end of the text are not intelligible.*

FDA Label Image

17224-672-60_2 (17224 672 60 2)

This is a prescription for Benzphetamine, a Schedule III controlled substance, containing 60 tablets of 50mg each. The patient is directed to take one tablet daily. The prescription is only available via electronic RX and has no refill option. The prescription includes the DEA # and two NDC #s for the drug. The label also has a cautionary statement about federal law prohibiting the transfer of the drug to anyone other than the patient it was prescribed to.*

FDA Label Image

Bmi Table (Figure 002 Bmi Table)

FDA Label Image

Chemical Structure (Figure 01 Chem Struc)

FDA Label Image

Company Logo (Figure 02 Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.